US Stock MarketDetailed Quotes
BLRX BioLine Rx
- 0.278
- -0.045-13.97%
Close Nov 22 16:00 ET
- 0.279
- +0.001+0.32%
Post 20:01 ET
23.39MMarket Cap-613P/E (TTM)
0.323High0.261Low5.97MVolume0.320Open0.323Pre Close1.71MTurnover7.75%Turnover RatioLossP/E (Static)84.11MShares1.89052wk High1.68P/B21.41MFloat Cap0.26152wk Low--Dividend TTM77.00MShs Float103.050Historical High--Div YieldTTM19.21%Amplitude0.261Historical Low0.286Avg Price1Lot Size
BioLine Rx Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.39M | 6.86M | 4.8M | 4.8M | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --5.39M | --6.86M | --4.8M | --4.8M | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 897K | 1.46M | 3.69M | 0 | 0 | 0 | ||||
| Gross profit | 4.5M | 5.4M | 1.11M | 0 | 0 | 0 | ||||
| Operating expense | 3.57%10.27M | 15.42%10.22M | 51.25%44.1M | 54.47%12.97M | 74.58%12.36M | 30.43%9.92M | 45.68%8.86M | 17.68%29.16M | 27.28%8.4M | 13.85%7.08M |
| Selling and administrative expenses | 16.43%8.04M | 49.42%7.73M | 171.83%31.23M | 93.12%9.52M | 255.48%9.63M | 213.05%6.91M | 214.60%5.17M | 118.05%11.49M | 244.69%4.93M | 109.35%2.71M |
| -Selling and marketing expense | 14.47%6.42M | 63.71%6.34M | 198.91%14.59M | -270.40%-3.02M | 517.39%8.13M | 383.94%5.6M | 508.16%3.87M | 547.48%4.88M | 7,595.65%1.77M | 433.20%1.32M |
| -General and administrative expense | 24.83%1.63M | 6.78%1.39M | 151.81%16.64M | 296.80%12.54M | 7.69%1.5M | 24.40%1.31M | 28.90%1.3M | 46.33%6.61M | 124.52%3.16M | 32.95%1.39M |
| Research and development costs | -25.98%2.23M | -32.30%2.49M | -28.99%12.52M | -9.56%3.1M | -37.58%2.73M | -44.28%3.01M | -16.93%3.68M | -9.44%17.63M | -33.09%3.43M | -11.25%4.37M |
| Depreciation amortization depletion | ---- | ---- | 800.00%351K | ---- | ---- | ---- | ---- | -7.14%39K | ---- | ---- |
| -Depreciation and amortization | ---- | ---- | 800.00%351K | ---- | ---- | ---- | ---- | -7.14%39K | ---- | ---- |
| Operating profit | 41.78%-5.77M | 45.55%-4.82M | -47.45%-42.99M | -41.27%-11.86M | -74.58%-12.36M | -30.43%-9.92M | -45.68%-8.86M | -17.68%-29.16M | -27.28%-8.4M | -13.85%-7.08M |
| Net non-operating interest income expense | -72.80%-1.55M | 6.67%-364K | 85.51%-162K | 404.43%1.65M | -232.28%-525K | -200.00%-897K | -227.73%-390K | -53.36%-1.12M | -139.82%-542K | 24.40%-158K |
| Non-operating interest income | 21.59%535K | 5.21%565K | 189.19%2.01M | 63.93%718K | 186.24%312K | 450.00%440K | 701.49%537K | 150.54%694K | 2,090.91%438K | 109.62%109K |
| Non-operating interest expense | 55.95%2.09M | 0.22%929K | 20.04%2.14M | -200.31%-957K | 213.48%837K | 252.77%1.34M | 398.39%927K | 81.50%1.79M | 424.18%954K | 2.30%267K |
| Total other finance cost | ---- | ---- | -3.85%25K | ---- | ---- | ---- | ---- | 18.18%26K | ---- | ---- |
| Other net income (expense) | 200.96%7.81M | 253.98%4.49M | -427.97%-17.46M | -214.40%-3.67M | -907.46%-3.14M | -1,788.43%-7.73M | -329.97%-2.92M | 443.93%5.32M | 27.34%3.21M | -45.21%389K |
| Gain on sale of security | ---- | ---- | -280.84%-10.99M | ---- | ---- | ---- | ---- | 467.53%6.08M | ---- | ---- |
| Special income (charges) | ---- | ---- | ---6.7M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | --6.7M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non- operating income (expenses) | 200.96%7.81M | 253.98%4.49M | 131.13%235K | 588.68%14.03M | -907.46%-3.14M | -1,788.43%-7.73M | -329.97%-2.92M | -812.26%-755K | -168.76%-2.87M | -45.21%389K |
| Income before tax | 102.61%484K | 94.28%-696K | -142.94%-60.62M | -142.28%-13.89M | -134.01%-16.02M | -149.16%-18.55M | -146.69%-12.16M | 7.77%-24.95M | -33.16%-5.73M | -19.79%-6.85M |
| Income tax | ||||||||||
| Net income | 102.61%484K | 94.28%-696K | -142.94%-60.62M | -142.28%-13.89M | -134.01%-16.02M | -149.16%-18.55M | -146.69%-12.16M | 7.77%-24.95M | -33.16%-5.73M | -19.79%-6.85M |
| Net income continuous Operations | 102.61%484K | 94.28%-696K | -142.94%-60.62M | -142.28%-13.89M | -134.01%-16.02M | -149.16%-18.55M | -146.69%-12.16M | 7.77%-24.95M | -33.16%-5.73M | -19.79%-6.85M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 102.61%484K | 94.28%-696K | -142.93%-60.61M | -142.26%-13.88M | -134.01%-16.02M | -149.16%-18.55M | -146.69%-12.16M | 7.77%-24.95M | -33.16%-5.73M | -19.79%-6.85M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 102.61%484K | 94.28%-696K | -142.93%-60.61M | -142.26%-13.88M | -134.01%-16.02M | -149.16%-18.55M | -146.69%-12.16M | 7.77%-24.95M | -33.16%-5.73M | -19.79%-6.85M |
| Basic earnings per share | 102.02%0.0061 | 93.59%-0.0096 | -100.00%-0.9 | -0.15 | -100.00%-0.3 | -100.00%-0.3 | 0.00%-0.15 | 25.00%-0.45 | 0 | 0.00%-0.15 |
| Diluted earnings per share | 102.02%0.0061 | 93.59%-0.0096 | -100.00%-0.9 | -0.15 | -100.00%-0.3 | -100.00%-0.3 | 0.00%-0.15 | 25.00%-0.45 | 0 | 0.00%-0.15 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data